Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Thrombosis and Haemostasis

• Publication date

  2012-04-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1160/TH11-10-0699PMID 22370911PMCID PMC3319843
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques

  2011cited by this paper
• Zn2+‐containing protein S inhibits extrinsic factor X‐activating complex independently of tissue factor pathway inhibitor

  2010cited by this paper
• Zinc Modulates the Interaction of Protein C and Activated Protein C with Endothelial Cell Protein C Receptor*

  2010cited by this paper
• Zinc ions bind to and inhibit activated protein C

  2010cited by this paper
• Plasma protein S contains zinc essential for efficient activated protein C‐independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor

  2009cited by this paper
• Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis.

  2009cited by this paper
• Identification of a protein S-interactive site within the A2 domain of the factor VIII heavy chain

  2009cited by this paper
• Species-specific anticoagulant and mitogenic activities of murine protein S

  2009cited by this paper
• Protein S enhances the tissue factor pathway inhibitor inhibition of factor Xa but not its inhibition of factor VIIa–tissue factor

  2008influential reference
• Hereditary Deficiency of Protein C or Protein S Confers Increased Risk of Arterial Thromboembolic Events at a Young Age: Results From a Large Family Cohort Study

  2008cited by this paper
• Soluble thrombomodulin is antithrombotic in the presence of neutralising antibodies to protein C and reduces circulating activated protein C levels in primates

  2006cited by this paper
• Protein S multimers and monomers each have direct anticoagulant activity

  2006cited by this paper
• Plasma contains protein S monomers and multimers with similar direct anticoagulant activity

  2006cited by this paper
• Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.

  2006cited by this paper
• The C4b-binding Protein-Protein S Complex Inhibits the Phagocytosis of Apoptotic Cells*

  2004cited by this paper
• Severe sepsis--a new treatment with both anticoagulant and antiinflammatory properties.

  2001cited by this paper
• A Novel Method for Efficient Drug Delivery

  1998cited by this paper
• Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII.

  1995cited by this paper
• Local delivery of an antithrombin inhibits platelet-dependent thrombosis.

  1994cited by this paper
• Protein S binds to and inhibits factor Xa.

  1994cited by this paper
• Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.

  1994cited by this paper
• Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C.

  1993cited by this paper
• Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.

  1993cited by this paper
• Gamma-carboxylated isoforms of recombinant human protein S with different biologic properties.

  1990cited by this paper
• Neonatal purpura fulminans associated with homozygous protein S deficiency.

  1990cited by this paper
• Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model.

  1989cited by this paper
• Plasma protein S deficiency in familial thrombotic disease.

  1984cited by this paper
• Regulation of activated protein C by a new protein. A possible function for bovine protein S.

  1980cited by this paper

• Proteome and Metabolome Profiling of Anticoagulant Disorders Induced by Familial Protein S Deficiency

  2024cites this paper
• Protein S contributes to the paradoxical increase in thrombin generation by low-dose dabigatran in the presence of thrombomodulin

  2024cites this paper
• Loss of protein C vs protein S results in discrepant thrombotic phenotypes

  2024cites this paper
• The thrombin generation capability of the Chacma baboon (Papio ursinus): implications for haemostatic disease models

  2023cites this paper
• Pleiotropic anticoagulant functions of protein S, consequences for the clinical laboratory. Communication from the SSC of the ISTH

  2021cites this paper
• Interspecies comparison of simultaneous thrombin and plasmin generation

  2020cites this paper
• Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis

  2018cites this paper
• Vitamin K–Dependent Protein S: Beyond the Protein C Pathway

  2017cites this paper
• The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

  2016cites this paper
• Protein S deficiency and novel oral anticoagulants: an intriguing case.

  2014cites this paper
• Plasma protein S residues 37–50 mediate its binding to factor Va and inhibition of blood coagulation

  2013cites this paper
• Protein S: an anticoagulant in its own right.

  2012cites this paper
• Platelet protein S directly inhibits procoagulant activity on platelets and microparticles

  2012cites this paper
• Protein S: an anticoagulant in its own right.

  2012cites this paper
• Protein S: An anticoagulant in its own right

  2012cites this paper
• Plasma protein S contains zinc essential for efficient activated protein C‐independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor

  2009cites this paper